GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovaQor Inc (OTCPK:INQR) » Definitions » Days Sales Outstanding

InnovaQor (InnovaQor) Days Sales Outstanding : 34.22 (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is InnovaQor Days Sales Outstanding?

InnovaQor's average Accounts Receivable for the three months ended in Sep. 2023 was $0.06 Mil. InnovaQor's Revenue for the three months ended in Sep. 2023 was $0.15 Mil. Hence, InnovaQor's Days Sales Outstanding for the three months ended in Sep. 2023 was 34.22.

The historical rank and industry rank for InnovaQor's Days Sales Outstanding or its related term are showing as below:

INQR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 3.54   Med: 50.27   Max: 68.69
Current: 30.23

During the past 8 years, InnovaQor's highest Days Sales Outstanding was 68.69. The lowest was 3.54. And the median was 50.27.

INQR's Days Sales Outstanding is ranked better than
69.27% of 641 companies
in the Healthcare Providers & Services industry
Industry Median: 46.87 vs INQR: 30.23

InnovaQor's Days Sales Outstanding declined from Sep. 2022 (65.51) to Sep. 2023 (34.22).


InnovaQor Days Sales Outstanding Historical Data

The historical data trend for InnovaQor's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovaQor Days Sales Outstanding Chart

InnovaQor Annual Data
Trend Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial - 3.54 68.69 63.82 36.71

InnovaQor Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.51 55.97 19.70 28.90 34.22

Competitive Comparison of InnovaQor's Days Sales Outstanding

For the Health Information Services subindustry, InnovaQor's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnovaQor's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovaQor's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where InnovaQor's Days Sales Outstanding falls into.



InnovaQor Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

InnovaQor's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (0.033 + 0.036) / 2 ) / 0.343*365
=0.0345 / 0.343*365
=36.71

InnovaQor's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (0.081 + 0.033) / 2 ) / 0.152*365 / 4
=0.057 / 0.152*365 / 4
=34.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InnovaQor  (OTCPK:INQR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


InnovaQor Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of InnovaQor's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


InnovaQor (InnovaQor) Business Description

Traded in Other Exchanges
N/A
Address
400 S. Australian Avenue, Suite 800, West Palm Beach, FL, USA, 33401
InnovaQor Inc provides information technology solutions and services to healthcare and laboratory customers in the United States. Its goal is to develop and deliver a technology-based medical professional's network communication platform to a broad range of healthcare professionals and businesses using a subscription revenue model with added value bolt-on services.
Executives
Francisco Iii Roca director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Darrell L Peterson director, officer: Chief Executive Officer 2390 CIRCLE DRIVE, WEST PALM BEACH FL 33406
Sharon Lynne Hollis director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Justin Doherty director 400 S. AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401
Thomas Joseph Bellante officer: Chief Financial Officer 14706 CROYDON PLACE, TAMPA FL 33618
Jayne Kirby officer: VP Finance 1035 LAURIER O., SUITE 200, MONTREAL A8 H2V 2L1
Arthur Gelston 10 percent owner 1035 LAURIER STREET WEST, MONTREAL A8 H2V 2L1
Visual Healthcare Corp 10 percent owner 790 ROCKLAND AVE., MONTREAL, QC. A8 H2V 2Z6
Philippe Rainville officer: CFO 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Philippe Panzini director 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Michel Maksud officer: VP Technology 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Gerard Dab director, officer: CEO and Chairman of the Board 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Louis J Lombardo director 108 SMITH LAKE ROAD, ROSCOE NY 12776
Visualmed Clinical Systems Corp 10 percent owner
Barry Scharf officer: VP Operations 391A LAURIER WEST, MONTREAL A8 H2V 2K3